New hope for rare blood disorder: Half-Matched transplants show promise

NCT ID NCT02828592

First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 23 times

Summary

This study tests a bone marrow transplant from a half-matched family donor for people with severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells. The approach uses a special drug after transplant to reduce complications. The goal is to see if this treatment can safely restore healthy blood cell production in patients who lack a fully matched donor.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE APLASTIC ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Blood and Marrow Transplant Group of Georgia

    RECRUITING

    Atlanta, Georgia, 30342, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Northside Hospital

    RECRUITING

    Atlanta, Georgia, 30342, United States

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.